BRÈVE

sur Jaguar Health, Inc. (NASDAQ:JAGX)

Jaguar Health Advisory Board Member to Present at ASCO Quality Care Symposium

Graphique de l'évolution du cours de l'action Jaguar Health, Inc. (EBR:JAGX).

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Stacey Tinianov, MPH, founder of Advocates for Collaborative Education (ACE), will present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium on September 27, 2024. The presentation, titled "Measuring what really matters: Advocacy-led co-creation and accrual of a pan-cancer QoL survey," will detail the methodologies used to design and execute "More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer."

Sponsored by Jaguar's Napo Pharmaceuticals, the survey aims to capture the diverse challenges faced by individuals diagnosed with cancer. "While cancer treatments have advanced, significant side effects can greatly affect quality of life," said Tinianov. "Common tools often miss what is most important to patients and survivors. Understanding these priorities can guide improvements in supportive care."

The survey was previously presented at the December 2023 San Antonio Breast Cancer Symposium. The abstract for the current presentation can be viewed online.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Jaguar Health, Inc.